SANGAMO THERAPEUTICS, INC. Accrued Liabilities, Current
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Accrued Liabilities, Current of $15.08 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-05-14
- 2026-03-31: Accrued Liabilities, Current $15.08M.
- 2025-12-31: Accrued Liabilities, Current $9.41M.
- 2025-09-30: Accrued Liabilities, Current $9.87M.
- 2025-06-30: Accrued Liabilities, Current $13.94M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-03-31 | $15.08M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $9.41M 10-Q · filed 2026-05-14 |
| 2025-09-30 | $9.87M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $13.94M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $9.80M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $8.20M 10-K · filed 2026-03-30 |
| 2024-09-30 | $11.63M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $15.76M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $18.47M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $23.55M 10-K · filed 2025-03-17 |
| 2023-09-30 | $14.23M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $18.96M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $15.39M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $16.01M 10-K · filed 2024-03-13 |
| 2022-09-30 | $14.05M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $14.20M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $14.10M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $11.58M 10-K · filed 2023-02-23 |
| 2021-09-30 | $14.82M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $15.45M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $13.76M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $18.61M 10-K · filed 2022-02-24 |
| 2019-12-31 | $10.88M 10-K · filed 2021-02-24 |